Updated Jul 16, 2026 · Last SEC filing 2026-07-01
WEST PHARMACEUTICAL SERVICES INC (WST) has filed 14 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-01. 6 Form 8-K material event filings were reported by WST in the last 90 days. 1 Form 144 notices of proposed sale were filed for WST stock. InsiderAlpha tracks every WST SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Surgical & Medical Instruments & Apparatus (SIC 3841) |
|---|---|
| SEC CIK | 0000105770 |
| Form 4 filings (90d) | 14 |
|---|---|
| Form 8-K filings (90d) | 6 |
| Form 144 notices (90d) | 1 |
| Latest Form 4 filing | 2026-07-01 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Campbell Shane Alden | SVP, Proprietary Segment | F — Tax withholding / forfeiture | 135 | $312.07 | $42K | SEC | |
| Campbell Shane Alden | SVP, Proprietary Segment | F — Tax withholding / forfeiture | 84 | $312.07 | $26K | SEC | |
| Campbell Shane Alden | SVP, Proprietary Segment | M — Option exercise | 474 | — | — | SEC | |
| Campbell Shane Alden | SVP, Proprietary Segment | M — Option exercise | 296 | — | — | SEC | |
| BUTHMAN MARK A | Director | A — Grant or award | 791 | $0.00 | — | SEC | |
| Lockhart Stephen H | Director | A — Grant or award | 791 | $0.00 | — | SEC | |
| LAI GOLDMAN MYLA | Director | A — Grant or award | 791 | $0.00 | — | SEC | |
| FRIEL ROBERT F | Director | A — Grant or award | 791 | $0.00 | — | SEC | |
| Keller Deborah L | Director | A — Grant or award | 791 | $0.00 | — | SEC | |
| HAUGEN JANET BRUTSCHEA | Director | A — Grant or award | 791 | $0.00 | — | SEC | |
| Joseph Molly | Director | A — Grant or award | 791 | $0.00 | — | SEC | |
| Feehery William F | Director | A — Grant or award | 791 | $0.00 | — | SEC | |
| Pucci Paolo | Director | A — Grant or award | 791 | $0.00 | — | SEC | |
| Michels Douglas A | Director | A — Grant or award | 791 | $0.00 | — | SEC | |
| Favorite Annette F | Sr. VP & Chief HR Officer | S — Open-market sale | 2.8K | $305.20 | $860K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for WEST PHARMACEUTICAL SERVICES INC (WST). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Campbell Shane Alden | 6 | $68K |
| Favorite Annette F | 3 | $1.09M |
| Winters Chad | 3 | $425K |
| HAUGEN JANET BRUTSCHEA | 2 | $17K |
| Lockhart Stephen H | 1 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in WST insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live WST dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.